Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow 0.00% Nasdaq Up0.52%

Acorda Therapeutics, Inc. (ACOR)

-NasdaqGS
34.99 Down 0.26(0.74%) 4:00PM EDT
|After Hours : 34.99 0.00 (0.00%) 4:47PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue 92,592   84,920   87,053   71,865  
Cost of Revenue18,536  17,372  17,092  13,643  
Gross Profit 74,056   67,548   69,961   58,222  
Operating Expenses
Research Development14,302  13,839  13,216  12,520  
Selling General and Administrative47,007  42,336  48,004  48,198  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 12,747   11,373   8,741   (2,496)
Income from Continuing Operations
Total Other Income/Expenses Net167  162  166  173  
Earnings Before Interest And Taxes12,914  11,535  8,907  (2,323)
Interest Expense286  544  749  591  
Income Before Tax12,628  10,991  8,158  (2,914)
Income Tax Expense6,437  3,513  4,247  (1,775)
Minority Interest -   -   -   -  
Net Income From Continuing Ops6,191  7,478  3,911  (1,139)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 6,191   7,478   3,911   (1,139)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 6,191   7,478   3,911   (1,139)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.